Susan Hasty, Publisher
Table of Contents . . . February 28th, 2006
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Drug Law Weekly | Other Publications
Amarin Corp. plc - Neuroscience drug maker reports loss of $0.10 per share
AtheroGenics, Inc. - Commercialization deal signed for atherosclerosis treatment
Bayer Group - Abbott Laboratories grants rights for new cancer and transplantation drug tests
Collaborations - Louisiana court partners with Southern University to evaluate substance abuse protocols
CytRx Corp. - Article indicates drug target RIP140 controls insulin sensitivity and glucose tolerance
Gastroesophageal Reflux Disease - Medicare increases reimbursement rate for Plicator procedure
Genetic Technologies, Ltd. - DNA-focused company expands licensing program, hires PatentBridge
GeoPharma, Inc. - Drugmaker announces dismissal of amended class action complaint relating to Mucotrol
Healthcare Costs - Administration says Medicare drug coverage will drop overall costs substantially
Healthcare Costs - Pediatricians vote to cut children's healthcare
Information Technology - Partners In Care participates in federally funded test of electronic prescribing program
J. Bolen Group, LLC - Dominion Diagnostics and "The Legal Side of Pain" announce a joint venture
Medicare - Pennsylvania governor seeks to expand comprehensive drug package for seniors
Medicare - Pharmacy services firm questions perceived savings of Medicare drug plan
NxStage Medical, Inc. - First patient enrolled in FREEDOM daily home hemodialysis study
ALZA Corp. - European Commission approves IONSYS
Advancis Pharmaceutical Corp. - Infectious disease-focused pharmaceutical firm appoints chairman of the board
Aga Khan University, Karachi - Reports advance knowledge in urology research
Alfacell Corp. - New thoracic cancer advisory board formed
All India Institute of Medical Science, New Delhi - Chemotherapy alone used to treat Hodgkin disease in Indian children
Alnylam Pharmaceuticals, Inc. - Public offering of common stock priced by RNAi therapeutics company
Apoxis SA - U.S. FDA grants orphan medicinal product designation for rare disease protein therapeutic
Archemix Corp. - Aptamer-based therapeutic developer moves to new headquarters
Arena Pharmaceuticals, Inc. - Phase I trial of Type 2 diabetes drug initiated
Ariad Pharmaceuticals, Inc. - Cancer drug developer reports loss of $0.99 per share, provides clinical pipeline update
Arpida, Ltd. - Good bioavailability reported from phase I trial of iclaprim
Athens University Medical School - Gastrinomas associated with MEN-1 syndrome
AtheroGenics, Inc. - Research and development collaboration with Astellas Pharma extended
Axonyx, Inc. - Data on Phenserine and Posiphen for Alzheimer disease to be presented in Geneva
Baker Heart Research Institute, Melbourne - Hypoalphalipoproteinemia in HIV/AIDS likely to be secondary to HIV infection itself
Behavior Disorders - Comprehensive Behavioral Care expands services to Maryland and Washington, DC
Behavioral Therapy - Brief relationship therapy was more cost effective than other therapies for alcohol addiction
Belfast City Hospital - Prolyl hydroxylase domain protein 2 is essential for hypoxia-inducible factor regulation
BioMS Medical Corp - Icon retained for phase II/III trial for MBP8298 to treat multiple sclerosis
Bionovo, Inc. - Phase II trial of MF101 launched for treatment of menopausal symptoms
Breast Cancer - Surgery best for controlling breast cancer in older women
Brigham & Women's Hospital, Boston - Pseudomonas vaccine elicits passive protection against corneal infection
British Columbia Center for Excellence in HIV/AIDS - Methadone maintenance therapy reduces heroin use and HIV risk behavior
Business & Finance - Drug development company subsidiary CDE certified for new market tax credit program
Business Update - Acadia Healthcare announces new operation
CV Therapeutics, Inc. - U.S. FDA approves Ranexa
Calando Pharmaceuticals, Inc. - Partnership formed to develop RNAi therapeutics for childhood cancer
California Department of Health Services - Heparin flush cause of Ralstonia pickettii bacteremia outbreak in neonatal ICU
Cardiff University - Nebivolol is novel beta-blocker with endothelium-derived NO enhancement benefit
Catholic University of Chile - Diurnal noninvasive ventilation beneficial in hypercapnic COPD
Cephalon, Inc. - Regulatory update provided on status of NUVIGIL
Charite Universitatsmedizin, Berlin - Laparoscopic staging enhances treatment planning for women with advanced cervical cancer
Chiba Cancer Center Research Institute - Adenovirus vector is more infective for esophageal and oral carcinoma cells
Chiba University - Tumor cell-stromal fibroblast interaction revealed in model of human small-cell lung cancer
Children's Medical Center of Israel - Antidepressant use in pregnancy appears associated with neonatal withdrawal symptoms
Children's Memorial Hospital, Chicago - HSCT feasible in infants with acute lymphoblastic leukemia
Chonbuk National University, Chonju - Flavonoids inhibited cell growth and induced apoptosis in osteosarcoma cells
Chronic Obstructive Pulmonary Disease - Emotional burden of COPD may make patients reluctant to seek treatment, survey shows
Cipher Pharmaceuticals, Inc. - Drugmaker provides CIP-Tramadol Extended Release update
Cleveland Clinic - Researchers studied natural history of valvular regurgitation in anorexigen-treated subjects
Cobalis Corp. - Dr. Gerald Yakatan joins allergy company's board of directors
Coley Pharmaceutical Canada - HBV CpG-optimized protein and DNA vaccines perform poorly in chimpanzees
CombinatoRx, Inc. - Collaboration to develop ophthalmic therapeutics built from synergistic drug combinations
ConjuChem, Inc. - PC-DAC:Exendin-4 to advance into human clinical testing for type 2 diabetes
Creighton University Cardiac Center, Omaha - Routine screening for antiplatelet drug resistance should not yet be standard practice
Cue Biotech, Inc. - Lundbeck, collaborator to discover allosteric modulators of G-protein coupled receptors
Dana Farber Cancer Institute, Boston - Alternative medicine use is not uncommon following genetic testing results for BRCA1/2
Decision Resources, Inc. - Generics erosion will lead to slow market growth for chronic heart failure treatment
Discovery Laboratories, Inc. - U.S. FDA grants Surfaxin fast track designation for prevention and treatment of BPD
Florida State University - Molecular mechanism discovered that inhibits HCV replication in vitro
GenExel-Sein, Inc. - U.S. FDA clears combined blood glucose, blood pressure monitor for home use
GlaxoSmithKline - U.S. FDA approves new formulation of Imitrex injection
Global AIDS Alliance - Call issued for Anglo-French alliance to combat AIDS epidemic
Hollis-Eden Pharmaceuticals, Inc. - Pharmaceutical firm responds to call for acute radiation syndrome therapy for U.S. forces
Insert Therapeutics, Inc. - Investigational New Drug Application filed to test safety of anticancer compound IT-101
Mercer University, Atlanta - Studies add new findings to diabetes therapy body of knowledge
Mylan Laboratories Inc. - Pharma company announces final U.S. FDA approval for alprazolam extended-release tablets
New River Pharmaceuticals Inc. - U.S. FDA accepts new drug application for NRP104 as treatment for ADHD
OptiMedica Corporation - Ocular disease technology company introduces new photocoagulator
Schering-Plough - U.S. FDA grants fast track designation to investigational oral HCV protease inhibitor
U.S. Centers for Disease Control & Prevention - Dengue proteins offer limited protection to interferon-deficient mice
U.S. Food & Drug Administration - Agency approves new treatment for gastrointestinal and kidney cancer
U.S. Food & Drug Administration - Scientists characterize hot-melt extruded poly(ethylene oxide) films
University of California, San Francisco - Vaginal swabs are best when screening for chlamydia and gonorrhea
University of Hong Kong - Avian influenza virus infections in humans are focus of review
University of Oklahoma - Pediatric immune response zones are established for Cylex ImmuKnow assay
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.